Oric Pharmaceuticals, Inc. ORIC Total Liabilities
Total Liabilities at other companies
Other financials
Where this comes from
Reported directly by Oric Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:Liabilities.
The official record: Oric Pharmaceuticals, Inc.’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →
Ask your AI about Oric Pharmaceuticals, Inc.'s total liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Oric Pharmaceuticals, Inc.'s total liabilities?
- Oric Pharmaceuticals, Inc. (ORIC) reported total liabilities of $21.21M in Q1 2026.
- How has Oric Pharmaceuticals, Inc.'s total liabilities changed year-over-year?
- Oric Pharmaceuticals, Inc.'s total liabilities decreased by 8.3% year-over-year, from $23.12M to $21.21M.
- What is the long-term trend for Oric Pharmaceuticals, Inc.'s total liabilities?
- Over 5 years (2020 to 2025), Oric Pharmaceuticals, Inc.'s total liabilities has grown at a 21.6% compound annual growth rate (CAGR), from $9.22M to $24.53M.
- What does total liabilities mean?
- The sum of all current and non-current obligations — everything the company owes to creditors, employees, governments, and other stakeholders.